Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | THPO | P40225 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butanedione SCHEMBL4889052 | 0.96 | TSHR (0.58) | TSHRTHPOLMNACA4FFAR3 | |
| Acetic Acid SCHEMBL29020590 | 0.82 | FFAR3 (0.64) | TSHRTHPOLMNACA4FFAR3 | |
| Acetic Acid SCHEMBL9050998 | 0.82 | FFAR3 (0.64) | TSHRTHPOLMNACA4FFAR3 | |
| Acetic Acid SCHEMBL5102108 | 0.82 | — | — | |
| Acetic Acid SCHEMBL31494927 | 0.82 | FFAR3 (0.64) | TSHRTHPOLMNACA4FFAR3 | |
| Butanedione SCHEMBL3273053 | 0.80 | — | — | |
| Butanedione SCHEMBL20472 | 0.80 | — | — | |
| Butanedione SCHEMBL1867426 | 0.80 | TSHR (1.00) | TSHRTHPOLMNACA4FFAR3 | |
| Acetamide SCHEMBL162386 | 0.78 | — | — | |
| Acetic Acid SCHEMBL28020370 | 0.78 | FFAR3 (0.58) | TSHRTHPOLMNAFFAR3LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1355855-A4 | PROCESSES FOR TREATING CORAL AND COATING AN OBJECT | NANOCOATINGS PTY LTD (AU) | 2005-12-14 | — | — | EP | claimed |
| US-20040091547-A1 | Processes for treating coral and coating an object | BIOTOMO PTY. LTD. (AU) | 2004-05-13 | — | — | US | claimed |
| EP-1355855-A1 | PROCESSES FOR TREATING CORAL AND COATING AN OBJECT | University of Technology, Sydney (AU) | 2003-10-29 | — | — | EP | claimed |
| WO-2002040398-A1 | PROCESSES FOR TREATING CORAL AND COATING AN OBJECT | UNIVERSITY OF TECHNOLOGY, SYDNEY (AU) | 2002-05-23 | — | — | WO | claimed |
| US-20080063683-A1 | Processes for treating coral and coating an object | NANOCOATINGS PTY. LTD. (AU) | 2008-03-13 | — | — | US | disclosed |
| US-7258898-B2 | Processes for treating coral and coating an object | NANOCOATINGS PTY, LTD. (AU) | 2007-08-21 | — | — | US | disclosed |
| EP-1355855-A4 | PROCESSES FOR TREATING CORAL AND COATING AN OBJECT | NANOCOATINGS PTY LTD (AU) | 2005-12-14 | — | — | EP | disclosed |
| US-20040091547-A1 | Processes for treating coral and coating an object | BIOTOMO PTY. LTD. (AU) | 2004-05-13 | — | — | US | disclosed |
| EP-1355855-A1 | PROCESSES FOR TREATING CORAL AND COATING AN OBJECT | University of Technology, Sydney (AU) | 2003-10-29 | — | — | EP | disclosed |
| WO-2002040398-A1 | PROCESSES FOR TREATING CORAL AND COATING AN OBJECT | UNIVERSITY OF TECHNOLOGY, SYDNEY (AU) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080063683-A1 | Processes for treating coral and coating an object | CA2, CA4, CA6 | TSHR 4240/4885THPO 1171/4885LMNA 4076/4885 |
| US-20040091547-A1 | Processes for treating coral and coating an object | CA2, CA4, CA6 | TSHR 4215/4885THPO 1159/4885LMNA 4041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.